HABILAX Trademark

Trademark Overview

On Monday, May 4, 2020, a trademark application was filed for HABILAX with the United States Patent and Trademark Office. The USPTO has given the HABILAX trademark a serial number of 88899807. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 23, 2023. This trademark is owned by Wockhardt Bio AG. The HABILAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation used as anti-infective
habilax

General Information

Serial Number88899807
Word MarkHABILAX
Filing DateMonday, May 4, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparation used as anti-infective

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWockhardt Bio AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZug 6300
CH
Party NameWockhardt Bio AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug 6300
CH

Trademark Events

Event DateEvent Description
Monday, October 23, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 23, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2023SOU EXTENSION 5 GRANTED
Monday, March 13, 2023SOU EXTENSION 5 FILED
Wednesday, March 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 13, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 7, 2022SOU EXTENSION 4 GRANTED
Wednesday, September 7, 2022SOU EXTENSION 4 FILED
Wednesday, September 7, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 11, 2022SOU EXTENSION 3 GRANTED
Friday, March 11, 2022SOU EXTENSION 3 FILED
Friday, March 11, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 21, 2021SOU EXTENSION 2 GRANTED
Tuesday, September 21, 2021SOU EXTENSION 2 FILED
Tuesday, September 21, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 15, 2021SOU EXTENSION 1 GRANTED
Monday, March 15, 2021SOU EXTENSION 1 FILED
Monday, March 15, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 22, 2020ASSIGNED TO EXAMINER
Friday, May 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 7, 2020NEW APPLICATION ENTERED

Related Keywords

habilax infective anti used preparation pharmaceutical